[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO930820L - PATHOGEN-SPECIFIC CTL THERAPY - Google Patents

PATHOGEN-SPECIFIC CTL THERAPY

Info

Publication number
NO930820L
NO930820L NO93930820A NO930820A NO930820L NO 930820 L NO930820 L NO 930820L NO 93930820 A NO93930820 A NO 93930820A NO 930820 A NO930820 A NO 930820A NO 930820 L NO930820 L NO 930820L
Authority
NO
Norway
Prior art keywords
pathogen
specific ctl
ctl therapy
patient
intracellular pathogen
Prior art date
Application number
NO93930820A
Other languages
Norwegian (no)
Other versions
NO930820D0 (en
Inventor
Judy Lieberman
Malcolm Gefter
Original Assignee
Immulogic Pharma Corp
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1991/006441 external-priority patent/WO1992004462A1/en
Application filed by Immulogic Pharma Corp, New England Medical Center Inc filed Critical Immulogic Pharma Corp
Publication of NO930820D0 publication Critical patent/NO930820D0/en
Publication of NO930820L publication Critical patent/NO930820L/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåte beskrives for behandling av en pasient infisert med en intracellulær patogen, hvilket omfatter til- førsel til pasienten av en intracellulær patogen-spesifikk, cytotoksisk T lymfocyt-stimulerend-2 antigen, eller et preparat av pasientens lymfocyter anriket for intracellulære patogen- spesif ikke cytotoksiske T lymofocyter.A method is described for treating a patient infected with an intracellular pathogen, which comprises administering to the patient an intracellular pathogen-specific, cytotoxic T lymphocyte-stimulating-2 antigen, or a preparation of the patient's lymphocytes enriched for intracellular pathogen-specific non-cytotoxic. T lymphocytes.

NO93930820A 1990-09-06 1993-03-05 PATHOGEN-SPECIFIC CTL THERAPY NO930820L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882890A 1990-09-06 1990-09-06
PCT/US1991/006441 WO1992004462A1 (en) 1990-09-06 1991-09-06 Pathogen-specific ctl therapy

Publications (2)

Publication Number Publication Date
NO930820D0 NO930820D0 (en) 1993-03-05
NO930820L true NO930820L (en) 1993-03-05

Family

ID=26783372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930820A NO930820L (en) 1990-09-06 1993-03-05 PATHOGEN-SPECIFIC CTL THERAPY

Country Status (1)

Country Link
NO (1) NO930820L (en)

Also Published As

Publication number Publication date
NO930820D0 (en) 1993-03-05

Similar Documents

Publication Publication Date Title
PL309002A1 (en) Therapeutic application of chimeric and radiotracer labelled antibodies, directed against the differentation antigen limited to human lymphocytes b, for treating lymphoma from lymphocytes b
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
DK1005870T3 (en) Therapeutic use of chimeric antibodies against human B lymphocyte differentiation antigen for the treatment of B cell lymphoma
AU4951196A (en) Vaccines for plague
DE69127470D1 (en) REINFORCING REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
FI19991893A (en) Controlled release of budesonide for oral administration and use of budesonide
DE69017915D1 (en) PREPARATION FOR THE STOMACH.
EP1298203A3 (en) Diagnosis and treatment of autoimmune diseases
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
NO922936L (en) PREPARATION OF FATIC ACID MEDICINES
AU3204489A (en) A synthetic antigen evoking anti-hiv response
ATE193442T1 (en) 3,4-DIARYL CHROMANES FOR THE TREATMENT OF DERMATITIS
GR1000419B (en) Dosage form for acalcium antagonist supply
SE8204873L (en) PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE
EP0137356A3 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
NO930820L (en) PATHOGEN-SPECIFIC CTL THERAPY
ATE58478T1 (en) PREPARATIONS AND METHODS FOR THE PROTECTION OF TLYMPHOCYTES AGAINST THE DISEASE AGENT OF LYMPHADENOPATHY AND ACQUIRED IMMUNE DEPRESSION SYNDROME.
KR950702838A (en) Method for inhibiting HIV replication using IL-4 using interleukin-4 (IL-4)
DE69127541D1 (en) PHARMACEUTICAL COMPOSITION
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
ATE111485T1 (en) PEPTIDE TREATMENT OF PERSISTENT INFECTIOUS DISEASES.
AU8501191A (en) Cross-reactive influenza a immunization
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.
SU1797350A1 (en) Method of detection of human immunodeficiency virus